Volunteers who took part in the Pfizer/BioNTech COVID-19 vaccine trial and received a placebo will be able to get a first dose of the vaccine by March 1. The trial’s Vaccine Transition Option means that all participants can find out if they were given the placebo. Trial participants will have two doses of the investigational vaccine reserved for them within the study.
That is a burden on their shoulders. Let's see how they hold up i n its pressure. Won't be long, soon be gone, we hope !! The virus !
Well if you don't go after your entire population it's easier to get a higher percentage. Maybe that's part of the final solution they have planned for the Palestinians. All they have to do is withhold the vaccine.